Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients

Publisher： Karger

E-ISSN： 1423-0216|23|5-6|345-351

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.23, Iss.5-6, 2017-04, pp. : 345-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study

By  

Neuroimmunomodulation, Vol. 20, Iss. 4, 2013-05 ,pp. : 213-222

Karger

Access to resources Recommend Favorite

Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy

By  

Neuroimmunomodulation, Vol. 19, Iss. 5, 2012-04 ,pp. : 283-292

Karger

Access to resources Recommend Favorite

Gonadotropin-Releasing Hormone Modulates Immune System Function via the Nuclear Factor-κB Pathway in Murine Raw264.7 Macrophages

By  

Neuroimmunomodulation, Vol. 16, Iss. 3, 2009-02 ,pp. : 177-184

Karger

Access to resources Recommend Favorite

Interferon β-1a Induces Tumor Necrosis Factor Receptor 1 but Decreases Tumor Necrosis Factor Receptor 2 Leukocyte mRNA Levels in Relapsing-Remitting Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 16, Iss. 3, 2009-02 ,pp. : 171-176

Karger

Access to resources Recommend Favorite

Decreased Level of sRAGE in the Cerebrospinal Fluid of Multiple Sclerosis Patients at Clinical Onset

By  

Neuroimmunomodulation, Vol. 21, Iss. 5, 2014-03 ,pp. : 226-233

Karger

Access to resources Recommend Favorite